Oxytocin Injection 10iu 1ml

• Powder: No
• Customized: Customized
• Certification: GMP, Copp
• Suitable for: Adult
• State: Liquid
• Purity: >99%
• Model NO.: ANTI-06-6
• Transport Package: Level 3
• Specification: 10IU 1ML
• Trademark: Serumpharm
• Origin: China
• HS Code: 2901231000

Product Description

OXYTOCIN INJECTION 10IU 1ML

Specification: 10IU 1ML
Trademark: Serumpharm
Support OEM/ODM: Yes
Mini. Order: 20000 Boxes
Delivery Time: 30~60 Days
Trade Term: FOB,CIF
Payment Term: T/T,L/C
Standard Available: CP,BP
Documents: GMP,COPP,CTD

OXYTOCIN INJECTION 10IU 1ML
Indications:
Induction of labour for medical reasons; stimulation of labour in hypotonic uterine inertia; during caesarean section, following delivery of the child; prevention and treatment of postpartum uterine atony and haemorrhage.
Early stages of pregnancy as a adjunctive therapy for the management of incomplete, inevitable, or missed abortion.
Dosage and Administration:
Caesarean section: 5 IU by slow iv injection immediately after delivery.
Prevention of postpartum uterine haemorrhage: The usual dose is 5 IU slowly iv after delivery of the placenta. In women given oxytocin for induction or enhancement of labour, the infusion should be continued at an increased rate during the third stage of labour and for the next few hours thereafter.
Treatment of postpartum uterine haemorrhage: 5 IU slowly iv, followed in severe cases by iv infusion of a solution containing 5 to 20 IU of oxytocin in 500ml of a non-hydrating diluent, run at the rate necessary to control uterine atony.
Incomplete, inevitable, or missed abortion: 5 IU slowly iv, if necessary followed by iv infusion at a rate of 20 to 40mU/min or higher.
Children: Not applicable.
Elderly: Not applicable.
Route of administration: Intravenous infusion or intravenous injection.
Warnings:
Administration of oxytocin at excessive doses results in uterine overstimulation with hypertonicity of the uterus and may cause reversible foetal distress.
Precautions for use:
For the induction of labour, administration of oxytocin by direct IM or IV injection is formally avoided. Administration by IV infusion should only be under qualified medical supervision.
Contra-indications:
Hypersensitivity to the active substance or to any of the excipients;
Dystocia;
Fragility or overdistension of the uterus;
Hypertonic uterine contractions or foetal distress, when delivery is not imminent; Pre-eclamptic toxaemia and severe cardiovascular disorders;
Predisposition to amniotic fluid embolism (foetal death in utero, retroplacentar hematoma);
Placenta praevia.
Drug interactions:
Some inhalation anaesthetics, e.g., cyclopropane or halothane, may enhance the hypotensive effect of oxytocin and reduce its oxytocic action.
When given during or after epidural anaesthesia, oxytocin may potentiate the pressor effect of sympathomimetic vasoconstrictor agents.
Prostaglandins :
Since it has been found that prostaglandins potentiate the effect of oxytocin and are risk factors of uterine rupture, it is not recommended that these drugs are used together. If used in sequence, the patient's uterine activity should be carefully monitored.
Pregnancy:
Animal reproduction studies have not been conducted with oxytocin. Based on the wide experience with this drug and its chemical structure and pharmacological properties, it is not expected to present a risk of foetal abnormalities when used as indicated.
Lactation:
Oxytocin may be found in small quantities in mother's breast milk. However, oxytocin is not expected to cause harmful effects in the newborn because it passes into the alimentary tract where it undergoes rapid inactivation.
Storage instructions:
Stored in a cool dark place (protected from light and not exceeding 20ºC).
 

Jiangxi Serum Pharma Industries Co.,Ltd. is a professional medical and pharmaceutical products supplier in China. We have been focused on exporting Biological products,Vaccines,Western medicines, APIs, Intermediates and medical products over 10 years, accumulating a wealth of experience. Our products have been exported to more than 30 countries, mainly in Asia, Africa, South America, Middle East and Europe, such as Philippines, Bangladesh,Laos,Cambodia, Kyrghyzstan, Cameroon, Guinea, Nigeria, Liberia, Mali, Yemen, Turkey, Chile, Australia and so on.Our finished products have won great popularity with reliable quality and competitive price,we have numerous end-users and good market reputation. 

We have developed advanced into the leading enterprise in pharmaceutical overseas exporting industry after years of efforts.Our products, including API and finished formulation, have been accredited with various certificates, such as Chinese GMP certificate, ISO9001 quality certificate.

The company has established close cooperation relations with domestic manufacturers of biological products, vaccines, raw material medicines and auxiliary materials, and has shared resources and complementary advantages. we are committed to the development and penetration of the international market and provide customers with quality assurance. We provide various pharmaceutical APIs and finished products with top quality at reasonable price and better after-sales service.

Our company has established a perfect quality assurance system in strict accordance with China's GMP requirements. The entire process from raw material procurement to finished product shipment is controlled by the quality assurance department.All raw materials are provided by selected reliable suppliers and carefully inspected by the Quality Assurance Department before use.

Excellence, Professionalism, and integrity are our cultures. We will offer good quality products with competitive prices and fast delivery for our customers. We are looking forward to setting up long-term cooperation relationship with you.